See also this year's filing and all EDGAR filings for this company.
PDF Report 0001178670_2023_ALNYLAM_PHARMACEUTICALS_INC.pdf
Logs
Graph
Absolute values for 0001178670, ALNYLAM PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,692,247,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 523,494,000 |
| 3 | remainder_Assets | 330,618,000 |
| 4 | LiabilitiesCurrent | 767,915,000 |
| 5 | LiabilitiesNoncurrent | 667,710,000 |
| 6 | remainder_Liabilities | 2,268,957,000 |
| 7 | CostOfGoodsAndServicesSold | 140,174,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 770,658,000 |
| 9 | ResearchAndDevelopmentExpense | 883,015,000 |
| 10 | remainder_Expenses | 32,806,000 |
| 11 | remainder_Revenues | 1,037,418,000 |
| 12 | remainder_NetIncome | -341,921,000 |
| 13 | remainder_ComprehensiveNetIncome | -11,395,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,546,359,000 |
| 1 | Liabilities | 3,704,582,000 |
| 2 | Expenses | 1,826,653,000 |
| 3 | Revenues | 1,037,418,000 |
| 4 | StockholdersEquity | -158,223,000 |
| 5 | NetIncome | -1,131,156,000 |
| 6 | ComprehensiveNetIncome | -1,136,853,500 |
| 7 | BaseVar | 5,234,164,000 |
| 8 | EconomicCapitalRatio | -0.389 |
Edgar->Model Mapping
Feature Distribution
Change over Time
